Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: Experience at an institution in southern China

Chinese Medical Journal

Volumn 122, Issue 13, 2009, Pages 1486-1491

  Song, Wu ^a   Wu, Sui Jing ^b   He, Yu Long ^a   Cai, Shi Rong ^a   Zhang, Chang Hua ^a   Zhang, Xin Hua ^a   Zhan, Wen Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Colorectal carcinoma; Mucinous adenocarcinoma; Prognosis; Signet ring cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHINA; CLINICAL FEATURE; COLLOID CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON MUCINOUS ADENOCARCINOMA; OVERALL SURVIVAL; PERITONEUM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 70349558077     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.13.002     Document Type: Article

References (23)

1. Zheng S. Prevention of colorectal carcinoma. Chin J Cancer Prev Treat (Chin) 2006; 13: 1-2
2. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopatho-logic characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 2000; 75: 103-107.
3. Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous Adenocarcinoma of the colorectum: a population-based study From an Asian country. Dis Colon Rectum 2004; 47: 78-85.
4. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ringcell carcinoma of the colon and rectum. Dis Colon Rectum 2005; 48: 1161-1168.
5. Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y, et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 2003; 46: 160-167.
6. Longo R, Morabito A, Carillio G, Lanzi G, Castellana MA, Amici S, et al. Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical course. Int J Gastrointest Cancer 2006; 37: 49-54.
7. Maksimović S. Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh 2007; 61: 26-29.
8. Human colorectal cancer. The Mouse Models of Human Cancers Consortium (MMHCC) Cancer Models Database. Available at: http://emice.nci.nih.gov/emice. Accessed March 2008.
9. Pathology and genetics, tumours of the digestive sys-tem. WHO classification of tumours. Lyon: IARC; 2000: 109.
10. Cserni G. Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 2003; 56: 327-335.
11. Younes M, Katikaneni PR, Lechago J. The value of the preoperative mucosal biopsy in the diagnosis of colorectal mucinous adenocarcinoma. Cancer 1993; 72: 3588-3592.
12. Kakar S, Aksoy S, Burgart LJ, Smyrk TC. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 2004; 17: 696-700.
13. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995; 75(1 Suppl): 154-170.
14. Adell R, Marcote E, Segarra MA, Pellicer V, Gamón R, Bayón AM, et al. Is mucinous colorectal adenocarcinoma a distinct entity? Gastroenterol Hepatol 2002; 25: 534-540.
15. Papadopoulos VN, Michalopoulos A, Netta S, Basdanis G, Paramythiotis D, Zatagias A, et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol 2004; 8 Suppl: 123-125.
16. Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, et al, Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 2008; 51: 50-55.
17. King-Yin Lam A, Ong K, Ho YH. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 2006; 49: 1275-1283.
18. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, et al. Microsatellite instability And the clinicopathological features of sporadi ccolorectal cancer. Gut 2001; 48: 821-829.
19. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE. Mucinous carcinoma: just another colon cancer? Dis Colon Rectum 1993; 36: 49-54.
20. Sugarbaker PH. Mucinous colorectal carcinoma. J Surg Oncol 2001; 77: 282-283.
21. Hanski C, Tiecke F, Hummel M, Hanski ML, Ogorek D, Rolfs A, et al. Low frequency of P53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett 1996; 103: 163-167
22. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88: 1739-1757.
23. Wu CS, Tung SY, Chen PC, Kuo YC. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol 1996; 11: 77-81.